Trial intelligence / Profile preview

Pilocarpine drops for dry mouth in adults with advanced cancer

ACTRN12610000840088Phase 3Not yet recruiting

Sponsor
The University of Queensland
Start
Nov 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, double-blind trial of pilocarpine in xerostomia (2 arms), sponsored by The University of Queensland. Primary endpoint: Symptomatic improvement measured by mean numerical rating scores for average dry mouth. Planned start Nov 2010; status: not yet recruiting.

02

Drugs

pilocarpine
03

Conditions

xerostomia

Beyond the preview

Go deeper on ACTRN12610000840088.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12610000840088.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call